Desmopressin Featured in New Umbrella Review on MS Urinary Symptoms

On October 16, 2026, a new publication titled "Management of Urinary Symptoms in Multiple Sclerosis: An Umbrella Review" was published in Neurourology and Urodynamics. The review addresses approaches to urinary symptom management in multiple sclerosis, with desmopressin named among the topics covered. The publication is an umbrella review, a format that compiles findings from existing reviews on a given subject. No specific results, outcomes, or efficacy data from the review were provided in the available event information. The article is indexed under PubMed ID 42885333 and is accessible through PubMed for readers seeking the full text and detailed content. Desmopressin remains an approved medication, and its inclusion in this review reflects its relevance to urinary symptom management discussions in the multiple sclerosis population. As with any newly published review, readers are encouraged to consult the original journal article for the complete scope of topics, methodology, and any conclusions drawn by the authors. This brief reports only the existence and basic bibliographic details of the publication as provided. For more background on desmopressin, including its approved uses and general profile, readers can refer to the compound overview.